BioSpace News Archive

Business

Dante Labs, Cambridge Cancer Genomics and Nonacus Collaborate to Provide Precision Oncology at Scale

Partnership aims to deliver the most comprehensive, cost effective and high throughput cancer sequencing and interpretation service in Europe, to enable improved cancer patient management, treatment, and monitoring

June 15, 2020
·
3 min read
Deals

Therapeutic Solutions International Issues “NOT US” Notice to Shareholders

Therapeutics Solutions International, Inc., issues the following cautionary notice to the shareholders and public at large.

June 15, 2020
·
6 min read
Business

Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer

Aridis Pharmaceuticals, Inc. announced that it has appointed Dr. Hasan Jafri as Chief Medical Officer. Dr. Jafri replaces Dr. Paul Mendelman who has been serving as the Company’s interim CMO since October, 2019 and will transition to the role of senior medical advisor to the Company.

June 15, 2020
·
7 min read
Business

Alligator Bioscience Appoints New CFO

Alligator Bioscience announced the appointment of Marie Svensson as Chief Financial Officer, CFO. Marie Svensson has more than 20 years of experience from various financial positions in the high-tech industry and will be a member of Alligator’s executive management team.

June 15, 2020
·
2 min read
Biotech Bay

Providence Medical Technology Announces First Patient Enrollment in the “FUSE” IDE Clinical Study

The FUSE Study is designed to demonstrate the superiority of Circumferential Cervical Fusion over traditional ACDF in patients at high risk for nonunion or revisions.

June 15, 2020
·
4 min read
MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO

Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership

June 15, 2020
·
4 min read
Drug Development

Xeris Pharmaceuticals Announces Positive Results From the Outpatient Stage of a Phase 2 Study of Its Developmental Gvoke Ready-to-Use (RTU) Micro™ Glucagon in Adults at Risk of Hypoglycemia During and After Aerobic Exercise

Results show a pre-treatment with a micro dose (150 µg) of Gvoke RTU Micro significantly prevented Exercise-Induced Hypoglycemia (EIH) during prolonged, moderate-to-high intensity aerobic exercise in a real-world setting with or without adjustment to insulin

June 15, 2020
·
10 min read
Genetown

Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies

MGTA-117 conditioning for precise depletion of cells in the bone marrow could potentially increase patients’ benefit from Beam’s base editing therapies for sickle cell disease and beta thalassemia

June 15, 2020
·
10 min read
Drug Development

IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings

Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-Related Macular Degeneration in a Phase 3 Trial

June 15, 2020
·
11 min read
Drug Development

Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Partner, Kaken Pharmaceutical

Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis

June 15, 2020
·
7 min read